Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue.
- 2014-04
- Anaerobe 26
- C. Hidalgo-Cantabrana
- M. Nikolić
- P. López
- A. Suárez
- Marija S. Miljković
- M. Kojić
- A. Margolles
- N. Golić
- P. Ruas-Madiedo
- PubMed: 24445155
- DOI: 10.1016/j.anaerobe.2014.01.003
Abstract
The effect of exopolysaccharide (EPS) producing bifidobacteria, and the EPS derived thereof, on the modulation of immune response was evaluated. Cells isolated from gut associated lymphoid tissue (GALT) and from peripheral blood mononuclear cells (PBMC) of naïve rats were used. The proliferation and cytokine production of these immune cells in the presence of the three isogenic Bifidobacterium animalis subsp. lactis strains (A1, A1dOx and A1dOxR), as well as their purified polymers, were in vitro analysed. The cytokine pattern produced by immune cells isolated from GALT showed that most levels remained stable in the presence of the three strains or their corresponding polymers. However, in PBMC the UV-inactivated bacteria induced higher levels of the ratios IFNγ/IL-17, TNFα/IL-10 and TNFα/TGFβ, and no variation in the ratio IFNγ/IL-4. Thus, B. animalis subsp. lactis strains were able to activate blood monocytes as well as T lymphocytes towards a mild inflammatory Th1 response. Furthermore, only the EPS-A1dOxR was able to stimulate a response in a similar way than its EPS-producing bacterium. Our work supports the notion that some bifidobacterial EPS could play a role in mediating the dialog of these microorganisms with the immune system. In addition, this study emphasizes the effect that the origin of the immune cells has in results obtained; this could explain the great amount of contradiction found in literature about the immunomodulation capability of EPS from probiotic bacteria.
Keywords: Bifidobacteria; Cytokine; Exopolysaccharide; GALT; Immune response; PBMC.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bifidobacterium animalis subsp. lactis | Improved Immune System Dialog via EPS | Neutral | Moderate |
Bifidobacterium lactis ISS Bif | Increased Cytokine Production in Peripheral Blood Mononuclear Cells | Neutral | Small |
Bifidobacterium lactis ISS Bif | Stable Cytokine Levels in Gut-Associated Lymphoid Tissue | Neutral | Small |